Brain stimulation trial to improve thinking in 22q11.2 deletion
Part of Blood & lymphatic, Bones, joints & muscles, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a non-invasive brain stimulation approach to help improve executive function—skills like planning, attention, and self-control—in people with 22q11.2 deletion syndrome. If you qualify, you would be asked to participate and allow study procedures to see whether this treatment helps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed genetic diagnosis of 22q11.2 deletion syndrome
- You are between 14 and 25 years old
- You and/or your caregiver are willing to take part in the study
- You (and your caregiver, if needed) can sign the consent forms
- You do not have epilepsy
- You do not have deep brain stimulation electrodes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a noninvasive brain stimulation treatment (tDCS) to improve thinking and memory problems in people with early schizophrenia. If you qualify, you would receive the study treatment while continuing stable schizophrenia care.
This trial tests whether mild brain stimulation (transcranial direct current stimulation or tDCS) over multiple sessions can improve thinking, behavior, and brain activity in adults with autism. It may help researchers learn if this safe, noninvasive treatment can support better daily functioning.
This study tests whether a non-painful brain stimulation method (tDCS) can improve attention and “thinking control,” and how brain activity changes during tasks. It also uses brain imaging (MRI), so safety and comfort conditions must be met.
This trial tests a type of brain stimulation (high-definition transcranial alternating current stimulation, or hi-tACS) to see if it can help with memory, attention, and other thinking skills in people with schizophrenia. You may join if you are clinically stable and on a steady dose of antipsychotic medication.
This study is testing a gentle, non-invasive brain stimulation technique (called tES) to see how it affects memory and thinking in people with memory problems. It involves light electrical stimulation applied to the scalp during sessions over several weeks.
This trial tests a noninvasive brain stimulation method (tACS) to see if it can improve thinking, memory, and social abilities in people with cerebellar conditions. It may help if you have a cerebellar malformation or degenerative atrophy and are between 12 and 32 years old.
Hear when a new 22Q11 Deletion Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.